Leukotriene A4 Hydrolase as a Target for Cancer Prevention and Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|4|3|267-283

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.4, Iss.3, 2004-05, pp. : 267-283

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel leukotriene A4 hydrolase inhibitors

By  

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 1, 1999-01 ,pp. : 91-95

Informa Healthcare

Access to resources Recommend Favorite

The centrosome as potential target for cancer therapy and prevention

By Korzeniewski Nina   Hohenfellner Markus   Duensing Stefan  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 1, 2013-01 ,pp. : 43-52

Informa Healthcare

Access to resources Recommend Favorite

Inhibitors of Leukotriene A4 (LTA4 ) Hydrolase as Potential Anti Inflammatory Agents

By  

Current Pharmaceutical Design, Vol. 7, Iss. 3, 2001-02 ,pp. : 163-179

Bentham Science Publishers

Access to resources Recommend Favorite

Par-4 as a potential target for cancer therapy

By Irby Rosalyn B   Kline Christina LB  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 1, 2013-01 ,pp. : 77-87

Informa Healthcare

Access to resources Recommend Favorite

NEDD4: A Promising Target for Cancer Therapy

By  

Current Cancer Drug Targets, Vol. 14, Iss. 6, 2014-07 ,pp. : 549-556

Bentham Science Publishers

Access to resources Recommend Favorite